65,437 trials
Immunologic Deficiency Syndromes
Primary: The Incidence of Acute Serious Bacterial Infections (SBI) — 0.04; 0; 0.02 Number of events per patient per year
Poikiloderma of Civatte · Dyschromia · Pigmentation Disorders
Primary: Severity Assessment Score — -0.06; 0.2 score on a scale
Essential Tremor
Primary: Clinical Rating Scale for Tremor (CRST) — 18.39534884; 13.97674419; 14.58139535 score on a scale — p=<0.01
Pre Diabetes
Primary: Progression From Prediabetes to Diabetes — 0; 1 Participants
Chronic Hepatitis Delta
Primary: Percentage of Participants With Combined Response at Week 48 — 2.0; 44.9; 48.0 percentage of participants — p=<0.0001
Severe Hypertriglyceridemia
Primary: Percent Change in Fasting TG From Baseline to Week 12 — -58.89; -22.94 Percent change — p=<0.0001
Human Immunodeficiency Virus
Primary: Number of Patients Who Receive Rapid HIV Treatment Initiation — 32 Participants
Alzheimer's Disease and Related Dementias
Primary: Change in Approaches to Dementia Questionnaire (ADQ) Total Score From Baseline to 3 Months — -1.8; -2.3 units on a scale
Type 1 Diabetes Mellitus
Primary: Change From Baseline in Hemoglobin A1c (HbA1c) — 0.04; -0.13 Percentage of HbA1c
Pain, Breast
Primary: Mean Visual Analog Scores — 4; 3.5; 4; 3.5 score on a scale
Non Small Cell Lung Cancer (NSCLC)
Primary: The Number of Participants With Treatment Related Select Adverse Events (Grade 3-4 and Grade 5) — 3; 0; 20; 0 Participants
Pediatrics · Anesthesia · Vasospasm
Primary: Number of Participants With Optimal Arterial Waveform — 27; 18 Participants
Cataract
Primary: Number of Participants in Each Treatment Group With a Successful Surface Anesthesia — 153; 152; 14; 19 participants
Healthy
Primary: Post Infusion Recovery of Test Platelets at End of Storage (Day 7) — 39.5; 57.8; 39.1; 60.4 percentage of infused platelets
Atrial Fibrillation (AF)
Primary: Number of Participants With Composite of International Society on Thrombosis and Hemostasis (ISTH) Major Bleeding or Clinically Relevant Non-major (CRNM) Bleeding — 3…